Dual Rapid HIV & Syphilis Tests in Zambia

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Completed
CT.gov ID
NCT02445846
Collaborator
World Health Organization (Other)
3,010
1
20
150.2

Study Details

Study Description

Brief Summary

The purpose of this study is to provide evidence on the performance and operational characteristics of commercially available dual HIV/syphilis Rapid Diagnostic Tests (RDTs) in Zambia for their introduction into antenatal care and other settings.

Condition or Disease Intervention/Treatment Phase
  • Device: dual HIV/syphilis rapid diagnostics tests

Detailed Description

Early detection and timely intervention of pregnant women infected with HIV and/or syphilis is critical. To improve the number of women tested and treated, the Centre for Infectious Disease Research in Zambia (CIDRZ) and the Ministry of Community Development, Mother and Health (MCDMCH) this field study will assess the effectiveness of newly developed dual HIV and syphilis rapid diagnostic tests (RDTs) manufactured by Chembio and Standard Diagnostics in Lusaka District antenatal clinics.

The specific objectives of this field performance evaluation of the rapid diagnostics are to determine the antenatal clinic-based performance of dual HIV/syphilis RDTs compared to that of current reference standard assays, and to assess the operational characteristics and acceptability of these dual HIV/syphilis RDTs to patients and health care providers This cross-sectional study of 3,765 pregnant women will validate the performance of Chembio and Standard Diagnostics dual HIV and Syphilis RDTs.

Study Design

Study Type:
Observational
Actual Enrollment :
3010 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Field Performance Evaluation of Dual Rapid HIV & Syphilis Tests in Zambia
Actual Study Start Date :
May 1, 2014
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Jan 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Pregnant women

Pregnant women, regardless of HIV status, seeking antenatal care at clinics in Lusaka, Zambia

Device: dual HIV/syphilis rapid diagnostics tests
Other Names:
  • Chembio and Standard Disgnostics
  • Outcome Measures

    Primary Outcome Measures

    1. performance of dual rapid HIV/syphilis tests [day 1/enrollment]

      The performance of the rapid study tests will be assessed by determining the specificity and the sensitivity when compared to reference standard assays

    Secondary Outcome Measures

    1. acceptability of use of dual rapid HIV/syphilis tests [day 1/enrollment]

      the operational characteristics and acceptability of the tests to patients and health care providers will be measured.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Pregnant women attending their first antenatal care visit at a study clinic

    • 18 years of age or older

    • Willing and able to provide informed consent for study participation

    Exclusion Criteria:
    • Prior participation in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Centre for Infectious Disease Research in Zambia Lusaka Zambia

    Sponsors and Collaborators

    • University of North Carolina, Chapel Hill
    • World Health Organization

    Investigators

    • Principal Investigator: Margaret Kasaro, MBChB, MSc, University of North Carolina, Chapel Hill

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    University of North Carolina, Chapel Hill
    ClinicalTrials.gov Identifier:
    NCT02445846
    Other Study ID Numbers:
    • 14-0528
    First Posted:
    May 15, 2015
    Last Update Posted:
    Apr 21, 2017
    Last Verified:
    Feb 1, 2017
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 21, 2017